Volume 53, Issue 26 pp. 6602-6616
Review

Thiopeptide Engineering: A Multidisciplinary Effort towards Future Drugs

Xavier Just-Baringo

Xavier Just-Baringo

Institute for Research in Biomedicine, Barcelona Science Park, University of Barcelona, Baldiri Reixac 10, 08028 Barcelona (Spain) http://www.pcb.ub.edu/fama/htm/home.htm

CIBER-BBN, Networking Centre on Bioengineering Biomaterials and Nanomedicine, 08028 Barcelona (Spain)

Search for more papers by this author
Prof. Fernando Albericio

Prof. Fernando Albericio

Institute for Research in Biomedicine, Barcelona Science Park, University of Barcelona, Baldiri Reixac 10, 08028 Barcelona (Spain) http://www.pcb.ub.edu/fama/htm/home.htm

CIBER-BBN, Networking Centre on Bioengineering Biomaterials and Nanomedicine, 08028 Barcelona (Spain)

Department of Organic Chemistry, University of Barcelona, 08028 Barcelona (Spain)

School of Chemistry and Physics, University of KwaZulu-Natal, 4000-Durban (South Africa)

Search for more papers by this author
Prof. Mercedes Álvarez

Corresponding Author

Prof. Mercedes Álvarez

Institute for Research in Biomedicine, Barcelona Science Park, University of Barcelona, Baldiri Reixac 10, 08028 Barcelona (Spain) http://www.pcb.ub.edu/fama/htm/home.htm

CIBER-BBN, Networking Centre on Bioengineering Biomaterials and Nanomedicine, 08028 Barcelona (Spain)

Laboratory of Organic Chemistry, Faculty of Pharmacy, University of Barcelona, 08028 Barcelona (Spain)

Institute for Research in Biomedicine, Barcelona Science Park, University of Barcelona, Baldiri Reixac 10, 08028 Barcelona (Spain) http://www.pcb.ub.edu/fama/htm/home.htmSearch for more papers by this author
First published: 23 May 2014
Citations: 80

Graphical Abstract

Making a complement: Modification of the structure of thiopeptides has produced numerous analogues that overcome some of their inherent limitations. The combined use of chemical synthesis, semisynthesis, and biosynthetic pathway engineering will allow the development of future thiopeptide-based drugs.

Abstract

The recent development of thiopeptide analogues of antibiotics has allowed some of the limitations inherent to these naturally occurring substances to be overcome. Chemical synthesis, semisynthetic derivatization, and engineering of the biosynthetic pathway have independently led to complementary modifications of various thiopeptides. Some of the new substances have displayed improved profiles, not only as antibiotics, but also as antiplasmodial and anticancer drugs. The design of novel molecules based on the thiopeptide scaffold appears to be the only strategy to exploit the high potential they have shown in vitro. Herein we present the most relevant achievements in the production of thiopeptide analogues and also discuss the way the different approaches might be combined in a multidisciplinary strategy to produce more sophisticated structures.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.